Remote Decentralized Clinical Trials Could Solve RCT Problems

IMI Project Aims To Establish New Paradigm For Clinical Trials

A new project by Europe’s Innovative Medicines Initiative that is comparing decentralized and traditional clinical trials was launched just before Janssen announced its own decentralized trial.

Render illustration of Clinical Trial title on medical documents — A new IMI Project Aims To Find A new Way Of Doing Clinical Trials

Europe’s Innovative Medicines Initiative has launched a new project, Trials@Home, to evaluate how remote decentralized clinical trials (RDCTs), which use new technologies to allow bigger, more diverse and remote populations to take part in clinical trials, could become the gold standard for clinical research. The project’s coordinator, Diederick Grobbee, explained to the Pink Sheet how RDCTs may replace traditional randomized control trials (RCTs).

The launch of the project came just before Janssen Pharmaceutical Cos. announced on 16 November its own decentralized trial...